A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY THE THE EFFICACY, SAFETY AND TOLERABILITY OF PONSEGROMAB Pfizer C3651003
Clinical Trial Grant
Awarded By
Pfizer, Inc.
Start Date
May 24, 2023
End Date
August 14, 2024
Awarded By
Pfizer, Inc.
Start Date
May 24, 2023
End Date
August 14, 2024